Chemotherapy: Gemcitabine remains the standard of care for pancreatic cancer

Nat Rev Clin Oncol. 2010 Mar;7(3):135-7. doi: 10.1038/nrclinonc.2010.16.
No abstract available

Publication types

  • News

MeSH terms

  • Antimetabolites, Antineoplastic / therapeutic use*
  • Clinical Trials as Topic
  • Deoxycytidine / analogs & derivatives*
  • Deoxycytidine / therapeutic use
  • Gemcitabine
  • Humans
  • Pancreatic Neoplasms / drug therapy*
  • Treatment Outcome

Substances

  • Antimetabolites, Antineoplastic
  • Deoxycytidine
  • Gemcitabine